[
    "{\"step_by_step_thinking\": \"The HVTN 702 trial is mentioned in several documents. Document [0] states that the ALVAC/gp120/MF59 vaccinations had no efficacy in HIV prevention in South Africa. Document [3] also confirms that the ALVAC-gp120 regimen did not prevent HIV-1 infection among participants in South Africa. Document [16] also mentions that the HVTN 702 trial was halted due to lack of evidence of efficacy. All these documents suggest that the ALVAC-HIV was not effective for HIV prevention in the HVTN 702 trial.\", \"answer_choice\": \"B\"}"
]